Narrative review / 2020
A review examined the therapeutic potential, mechanisms, efficacy, and safety of four medicinal plants in cardiovascular disease management.
This review evaluates the ethnopharmacological therapeutic potential, mechanisms, efficacy, and safety of Ginseng, Ginkgo biloba, Ganoderma lucidum, and Gynostemma pentaphyllum for cardiovascular diseases. It synthesizes findings from in vitro, in vivo, and clinical trial studies covering conditions such as hypertension, coronary heart disease, myocardial infarction, cardiomyopathies, peripheral vascular diseases, and dyslipidemias. The authors emphasize that while these herbs demonstrate therapeutic promise against CVD risk factors, their claimed safety requires proper testing due to potential toxicity, adverse effects, and herb-drug interactions.
- Study type
- Narrative review
- Who was studied
- Patients with cardiovascular diseases (in reviewed clinical trials)
- What was measured
- Efficacy, mechanisms, safety, toxicity, and herb-drug interactions in CVDs
THE PAPER
Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety.
Shaito A, Thuan DTB, Phu HT, Nguyen THD, Hasan H, Halabi S, Abdelhady S, Nasrallah GK, Eid AH, Pintus G. Front Pharmacol, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.